Prescription Drug Affordability Board RAC

The Prescription Drug Affordability Board (PDAB) is established in the Department of Consumer and Business Services (DCBS) to protect residents of this state, state and local governments, commercial health plans, health care providers, pharmacies licensed in this state and other stakeholders within the health care system in this state from the high costs of prescription drugs. Enrolled Senate Bill 844 (2021) gives DCBS authority to establish the PDAB.

The Division of Financial Regulation, in consultation with the PDAB, is entering rulemaking to establish annual fees to be paid by manufacturers that sell prescription drugs in this state and the affordability review process. 

PUBLIC HEARINGS: Learn about public hearing schedules for the Prescription Drug Affordability Board: Public Hearings

All meetings held via Microsoft Teams meetings.
Join on your computer or mobile app.*
*Download the Microsoft Teams app

Committee Contacts:

Cortnee Whitlock
Policy Analyst
Cortnee.WHITLOCK@dcbs.oregon.gov
Phone: 971-374-3766

Karen Winkel
Rules Coordinator
Karen.J.WINKEL@dcbs.oregon.gov
Phone: 503-947-7694 

June 22, 2023

Documents and info:

• Rulemaking hearing notice
  June 22, 2023
  

• Rules affected: OAR 925-200-0010, 925-200-0020

  Filed: 05/23/2023
  

  Public hearing: 06/22/2023, 11:00 AM - 11:45 AM

  Last day for public comment: 06/29/2023, 5:00 PM
  

April 5, 2023

Documents:

• Agenda
  April 5, 2023 Agenda
• Draft rules
  Draft affordability review
  
• Statement of Need and Fiscal Impact 
  SNFI for discussion
  
• Adopted rules:
  PDAB 2-2022: Model Rules for Rulemaking and Public Records Requests

The below list of names are invited RAC members. There will be time at the end of the RAC meeting to accept public comment from members of the public. If you plan to provide public comment during the RAC meeting, we encourage you to send in your written public comment either in advance or following the RAC meeting.

Committee members